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Proteomic Proﬁling of Enteroid Cultures Skewed toward
Development of Speciﬁc Epithelial Lineages
Lisa Luu, Zoe J. Matthews, Stuart D. Armstrong, Penelope P. Powell, Tom Wileman,
Jonathan M. Wastling, and Janine L. Coombes*
Recently, 3D small intestinal organoids (enteroids) have been developed from
cultures of intestinal stem cells which diﬀerentiate in vitro to generate all the
diﬀerentiated epithelial cell types associated with the intestine and mimic the
structural properties of the intestine observed in vivo. Small-molecule drug
treatment can skew organoid epithelial cell diﬀerentiation toward particular
lineages, and these skewed enteroids may provide useful tools to study
speciﬁc epithelial cell populations, such as goblet and Paneth cells. However,
the extent to which diﬀerentiated epithelial cell populations in these skewed
enteroids represent their in vivo counterparts is not fully understood. This
study utilises label-free quantitative proteomics to determine whether
skewing murine enteroid cultures toward the goblet or Paneth cell lineages
results in changes in abundance of proteins associated with these cell
lineages in vivo. Here, proteomics data conﬁrms that skewed enteroids
recapitulate important features of the in vivo gut environment, demonstrating
that they can serve as useful models for the investigation of normal and
disease processes in the intestine. Furthermore, comparison of mass
spectrometry data with histology data contained within the Human Protein
Atlas identiﬁes putative novel markers for goblet and Paneth cells.
The small intestine is organized into protruding ﬁnger-like villi,
and crypts of Lieberku¨hn which extend into the muscularis mu-
cosae. These structures are covered by a single layer of epithe-
lium consisting of specialized cell types, including absorptive
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enterocytes, goblet cells, enteroendocrine
cells, M cells, and Paneth cells.[1,2] Gob-
let and Paneth cells play crucial roles
in protecting the host from microbial
invasion, and in regulating the com-
mensal ﬂora. Goblet cells produce a
protective mucus layer that is loosely
adhered to the intestinal epithelium, and
acts as a barrier to pathogen coloniza-
tion and invasion.[3,4] Furthermore, they
have been shown to play a role in lu-
minal antigen sampling across the small
intestinal epithelium.[5] Paneth cells re-
side at the crypt base, and secrete an-
timicrobial compounds into the crypt lu-
men following microbial stimulation.[6–9]
Systems-based approaches have the po-
tential to provide a more holistic view of
the development and host-protective role
of these epithelial cell populations. How-
ever, their relative scarcity in the epithe-
lial cell layer, combined with complexi-
ties in the isolation and culture of these
cells, pose a signiﬁcant barrier to the
application of unbiased proﬁling techniques, such as proteomics,
to study these cells.
The small intestinal epithelium undergoes regular renewal
via shedding of epithelial cells into the mucus layer, which is
removed along with other gastrointestinal waste. Intestinal ep-
ithelial regeneration requires the presence of LGR5+ stem cells,
which reside at the crypt base and are capable of generating all the
specialized epithelial cell types found in the small intestine.[10,11]
AWnt gradient exits along the crypt-villus axis, originating in the
crypt domain. Wnt-signalingmaintains LGR5+ cell proliferation
in the crypt. As daughter cells migrate along the Wnt gradient,
crosstalk between Wnt, Notch, and BMP signaling determines
cell fate, giving rise to diﬀerentiated epithelial lineages. These
renewal properties can be exploited to generate 3D organoid cul-
tures (called enteroids) from isolated intestinal LGR5+ stem cells
or crypts.[12] When cultured inMatrigel R© with a cocktail of growth
factors, LGR5+ stem cells generate the diﬀerentiated epithelial
cell types found in the small intestine, arranged in crypt-villus
structures that mimic the complex intestinal architecture ob-
served in vivo.[12] Since the initial description of these cultures
in 2009, there has been a dramatic uptake in their use as in vitro
models of a variety of diﬀerent physiologic and pathologic pro-
cesses. Consequently, characterization of the enteroid proteome
would serve as a valuable resource in this growing ﬁeld.
Enteroids can be treated with small molecule inhibitors
to skew cell diﬀerentiation toward speciﬁc lineages.[13–15] For
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Figure 1. Drug treatment skews enteroids toward Paneth or goblet cell lineages. Intestinal enteroids were treated with DAPT/CHIR or DAPT/IWP-2 to
promote diﬀerentiation toward the Paneth or goblet cell lineages, respectively. A) Volcano plot depicting changes in protein expression between control
and Paneth-skewed enteroids. B) Top ten proteins up- and downregulated in Paneth-skewed enteroids C) Volcano plot depicting changes in protein
expression between control and goblet-skewed enteroids. D) Top ten proteins up- and downregulated in goblet-skewed enteroids.
example, the combination of DAPT and CHIR99021, which in-
hibit notch signaling and GSK3β-mediated β-catenin degrada-
tion, respectively, directs epithelial cell diﬀerentiation toward the
Paneth cell lineage.[15] If DAPT is instead combined with an
inhibitor of Wnt signaling, IWP-2, epithelial cells are directed
along the secretory cell lineages resulting in cultures enriched
for goblet cells.[15] These skewed enteroids might allow systems
approaches to be applied to study the host-defensive properties
of specialized intestinal epithelial cells that have up until now
evaded culture “in vitro.” However, the extent to which diﬀeren-
tiated epithelial cell populations generated from enteroids repre-
sent their in vivo counterparts is not fully understood.[16–23]
Four biological replicates of drug-skewed enteroid cultures
were generated frommurine small intestinal crypts essentially as
previously described.[12] For drug skewing, media was changed
on days two, ﬁve and seven to include 10 μm DAPT and either
3 μm CHIR99021 or 2 μm IWP-2 (Tocris, Oxford, UK).[15] On day
eight, enteroids were ﬁxed and prepared for confocal imaging as
described in Supporting Information.
In DAPT and CHIR-treated enteroids (“Paneth-skewed”), we
observed a higher proportion of cells stained with a Paneth cell
marker, lysozyme, compared to control cultures (Figure S1A,
Supporting Information). In DAPT and IWP-2-treated enteroids
(“goblet-skewed”), we observed a greater proportion of cells
stained with the goblet cell marker, MUC2, when compared to
control enteroid cultures (Figure S1B, Supporting Information).
These changes in expression of canonical markers of diﬀerenti-
ated epithelial cell types conﬁrm the success of small molecule
inhibitors in directing the diﬀerentiation of LRG5+ stem cells
toward speciﬁc epithelial cell lineages.
For mass spectrometry, a minimum of 50 organoids per treat-
ment group were extracted from Matrigel using Cell Recov-
ery Solution (BD Bioscience). Proteins were extracted in solu-
tion using 50 mm ammonium bicarbonate, 0.2% w/v Rapigest
(Waters) and protein content was normalized between samples.
Trypsin digested peptidemixtures (2μL) were analyzed by online
nanoﬂow liquid chromatography using the nanoACQUITY-nLC
system (Waters MS technologies, Manchester, UK) coupled to
an LTQ-Orbitrap Velos (ThermoFisher Scientiﬁc, Bremen, Ger-
many) mass spectrometer with the manufacturer’s nanospray
ion source. Sample injectionswere not grouped by treatment type
to avoid any batch bias. Protein identiﬁcation and quantiﬁcation
were performed using Progenesis LC-MS for proteomics (v 4.1,
NonlinearDynamics) and theMascot search engine (v 2.3.02,Ma-
trix Science), using the parameters described in Supporting In-
formation. Themass spectrometry proteomics data have been de-
posited to the ProteomeXchange Consortium via the PRIDE part-
ner repository with the dataset identiﬁer 10.6019/PXD005006.[2,3]
Using an exclusion criteria of 2 peptides identiﬁed, we
identiﬁed a total of 1574 proteins in Paneth-skewed, and 1471
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Figure 2. Intestinal expression patterns of proteins upregulated in Paneth-skewed cultures. Proteins upregulated in Paneth-skewed enteroids were cross-
referenced with immuno-histochemical staining of normal human tissue available in the Protein Atlas. A–B) Immuno-histochemical staining for known
Paneth cell markers DEFA5 and LYZ. C–G) Immuno-histochemical staining for a selection of proteins found to be upregulated in Paneth-skewed enteroid
cultures, and also expressed in Paneth cells in human intestinal tissue. Pink regions highlight crypts, while green regions highlight villi. Arrows indicate
Paneth cells (in crypt regions) or goblet cells (in villus regions). Images from v13.proteinatlas.org.
proteins in goblet-skewed enteroids. Applying exclusion criteria
of log2 fold change >1 and q-value (ANOVA) < 0.05 (FDR ad-
justed p-value), 36 proteins were upregulated and 65 proteins
were downregulated in Paneth-skewed enteroids compared to
untreated controls (Figure 1A,B and Table S1, Supporting Infor-
mation). In goblet-skewed enteroids, 55 proteins were upregu-
lated, and 153 downregulated compared to untreated controls
(Figure 1C,D and Table S2, Supporting Information). Thus, treat-
ment with DAPT/CHIR or DAPT/IWP-2 results in distinct pat-
terns of protein expression.
We next determined if the observed changes in protein abun-
dance in Paneth-skewed cultures were reﬂective of known fea-
tures of Paneth cells observed in vivo. Matrilysin (MMP7), a
known marker of Paneth cells required for activation of pro-α-
defensins, was signiﬁcantly upregulated (log2 fold change= 1.78,
q-value 0= 0.00093, Table S1, Supporting Information).[24] We
also observed an increased abundance of several α-defensins
(DEFA4, DEFA5, DEFA7, DEFA20, DEFA22, DEFA24) though
none reached statistical signiﬁcance. To conﬁrm that proteins
found to be signiﬁcantly upregulated in Paneth-skewed cul-
tures were also expressed by Paneth cells in vivo, we performed
searches for human homologues of the proteins on the Hu-
man Protein Atlas (http://v13.proteinatlas.org, and Supporting
Information).[25] Paneth cells were identiﬁed as granular cells re-
siding at the base of small intestinal crypts, and antibody stain-
ing for Paneth cell products, lysozyme (LYZ), and defensin α5
(DEFA5), used as a reference (Figure 2A,B). Of the 36 proteins
upregulated, expression of MMP7, KIAA1324, SLC27A4, and
DNAJC3 was restricted to, or enriched within, Paneth-like cells
(Figure 2C–F). Of these proteins, only MMP7 and DNAJC3 were
uniquely upregulated in Paneth-skewed enteroids. To cope with
their secretory demands, Paneth cells require a highly developed
endoplasmic reticulum (ER)[26] which is protected from ER stress
by the unfolded protein response (UPR). Intestinal epithelial cell-
speciﬁc deletion of the UPR gene, Xbp1, leads to induction of ER
stress, and a profound defect in Paneth cells.[27] Since DNAJC3
also plays a role in attenuation of ER stress,[26] we hypothesize
that DNAJC3 may be important for Paneth cell development and
function.
Goblet cells secrete mucins which form a protective mucus
layer that maintains physical separation between the host ep-
ithelium and colonizing microbes. To determine if the observed
changes in protein abundance in goblet-skewed cultures were
reﬂective of diﬀerentiation toward the goblet cell lineage, pro-
teomic proﬁles were cross-compared with a published database
of murine small intestinal mucus components.[28] Of the 56
signiﬁcantly upregulated proteins within our goblet-skewed en-
teroids, 14 (25%) were also detected in murine gastrointesti-
nal mucus[28] (Table S3, Supporting Information). Of these,
CLCA1 (log2 fold change = 3.328, q-value = 0.00347), AGR2
(log2 fold change = 1.857, q-value = 0.04257) and ZG16 (log2
fold change = 2.26, q-value = 0.03612) are among the most
highly abundant constituents of gastrointestinalmucus. Our data
therefore support the idea that goblet-skewed enteroid cultures
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Figure 3. Intestinal expression patterns of proteins upregulated in goblet-skewed cultures. Proteins upregulated in goblet-skewed enteroids were cross-
referenced with immuno-histochemical staining of normal human tissue available in the Protein Atlas. A) Immuno-histochemical staining for a known
goblet cell marker, TFF3. A–D) Immuno-histochemical staining for a selection of proteins found to be upregulated in goblet-skewed enteroid cultures,
and also expressed in goblet cells in human intestinal tissue. Pink regions highlight crypts, while green regions highlight villi. Arrows indicate Paneth
cells (in crypt regions) or goblet cells (in villus regions). Images from v13.proteinatlas.org.
accurately recapitulate the in vivo environment, and may be use-
ful models of goblet cell function. Indeed, goblet skewed colonic
enteroids have been used to study the role of autophagy genes in
mucus secretion.[29]
To further conﬁrm that proteins found to be signiﬁcantly
upregulated in goblet-skewed cultures were also expressed by
goblet cells in vivo, we again performed searches for hu-
man homologues of the proteins in The Human Protein At-
las (http://v13.proteinatlas.org, and Supporting Information).[25]
Goblet cells were identiﬁed based on the presence ofmucin gran-
ulae ﬁlling the cytoplasm at the apical surface, and antibody stain-
ing for a canonical marker of goblet cells, TFF3, was used as
a reference (Figure 3A). Of the 55 proteins upregulated, TFF3,
CLCA1, ZG16, and UGT2B17 expression was restricted to, or
enriched within, goblet cells (Figure 3A–D). TFF3, CLCA1, and
ZG16 have previously been associated with mucus production.
Across a large panel of normal tissues encompassing all ma-
jor organ systems, the Human Protein Atlas states that goblet
cells show the strongest positivity for the remaining protein,
UGT2B17.
Finally, we observed some commonalities in the proteins
up- or downregulated in response to both DAPT/CHIR or
DAPT/IWP-2 treatment. For example, OLFM4, an anti-apoptotic
factor and marker of intestinal stem cells, was signiﬁcantly
downregulated under both treatment conditions, while expres-
sion of the canonical enteroendocrine cell marker, CHGA, was
signiﬁcantly upregulated in both Paneth- and goblet-skewed
enteroids (Table S4, Supporting Information). This result is
in close agreement with a previous study which used chga
mRNA levels to show that treatment with both DAPT/CHIR
and DAPT/IWP-2 results in increased diﬀerentiation toward the
enteroendocrine lineage.[15] Finally, UPP1 and NUCB2 staining
were observed in both Paneth and goblet cells (Figure 3E,F).
In this study, we have subjected murine enteroids to quanti-
tative label-free proteomics, and shown that Paneth and goblet
cells generated from intestinal stem cells in vitro share features
typical of these cell types observed in vivo. This study has also led
to the identiﬁcation of novel protein markers not previously as-
sociated with these cell populations. Our data therefore support
the use of Paneth- or goblet-skewed enteroids as a means of ap-
plying systems approaches to the study of infection of intestinal
epithelial surfaces with pathogens.
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Supporting Information is available from the Wiley Online Library or from
the author.
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